Pharmaceutical Committee, Veterinary Pharmaceutical Committee
The Pharmaceutical Committee is an advisory Committee which was set up by Council Decision 75/320/EEC of 20 May 1975 with the task of examining all questions relating to medicinal products for human use including matters related to the preparation of new legislative initiatives. The Committee consist of senior experts in public health matters from the Member States' administrations and are chaired by a Commission representative.
The Veterinary Pharmaceutical Committee examines all questions relating to veterinary medicinal products including matters related to the preparation of new legislative initiatives.
The Committees may also be convened as an expert group in the preparation of secondary legislation and Commission guidelines.
- Human Pharmaceutical Committee - Meetings
- Veterinary Pharmaceutical Committee - Meetings
- Joint Pharmaceutical and Veterinary Pharmaceutical Committee - Meetings
Expert groups
Experts groups are consultative bodies that advise the Commission on the preparation of legislative proposals and policy initiatives, the implementation of legislation, programmes and existing Union policies, and the preparation of delegated acts. The Commission and its services remain fully independent with regard to taking into account the views expressed by expert groups. Groups created by Directorates General of the Commission, are published in the Register of Commission expert groups and other similar entities.
- Pharmaceutical Committee – Expert group on delegated acts – Meetings
- Notice to Applicants
- Commission Expert group on Safe and Timely Access to Medicines for Patients ("STAMP")
- Technical expert seminar on pharmaceuticals related matters, following UK withdrawal (8 March 2018)
- Ad-hoc technical meeting under the Pharmaceutical Committee on shortages of medicines, 25 May 2018
